Management of Hepatogenous Diabetes in a Liver Transplant Patient Through Blood Sugar Regulation: A Case Report

14 Pages Posted: 18 Feb 2021

See all articles by Annie Lin

Annie Lin

Maryland Univ Integrative Health

Lillie Nguyen

Maryland Univ Integrative Health

Michelle Avent

Maryland Univ Integrative Health

Stephanie Lanham

Maryland Univ Integrative Health

Date Written: December 6, 2020

Abstract

Background: Liver dysfunction causing hepatogenous diabetes (HD) is difficult to diagnose and research is limited. This case implemented a novel approach for managing hepatogenous diabetes with nutrition intervention.

Case Description: The 55-year old malnourished male patient with a history of hepatitis C (HCV) and chronic liver disease (cirrhosis) underwent liver transplantation in 2016. He was also diagnosed with hemochromatosis, diabetes and a low serum magnesium prior to liver transplantation. He is married with children and without a history of alcohol, smoking, or drug use. There was no family history of diabetes or hemochromatosis.

The patient was first diagnosed with HCV in 2006 and unsuccessfully treated with interferon (peg-IFN) plus ribavirin. He was placed on a liver transplant list in 2011. In the interim he was treated for: - Low hemoglobin which eventually led to hemochromatosis secondary to transfusions, - Chronic abdominal pain, ascites and anasarca requiring hospitalization - Malnourishment, nausea, jaundice, itchy skin, loss of appetite loss, - Diabetes (2015), with wide ranging fasting glucose from 46-325. - Hepatic encephalopathy prior to his liver transplant in January 2016.

He was prescribed multiple medications for abdominal pain: morphine, hydromorphone, dilaudid, oxycontin, and tramadol. He was also prescribed rifaximin, lactulose, lasix and albumin; and insulin for his diabetes. During liver transplantation he suffered two cardiac arrests and ischemic brain injury, requiring five months of hospitalization. He was referred for a nutritional consultation for assistance with diabetes management, muscle atrophy, and chronic gastro-intestinal symptoms. Current medications include Cyclosporine and Mycophenolate (both calcineurin inhibitors) and prednisone. Other medications included metformin, onlgyza, and kombiglyze, and a sliding scale for insulin.

Follow-up with the nutritionist continued for 4 years. involving monitoring every 8-16 weeks combined with motivational interviewing. Interventions were modified to honor the patient’s cultural and social needs, (e.g. fasting for the religious practice of Ramadan, prayer, religious rituals, weekly congregations, and art). A patient-centered process is likely to increase adherence. Although interventions were successful managing blood sugar, the patient occasionally experienced hypoglycemia with exercise. There were no other reported adverse outcomes, such as neuropathy or diabetic retinopathy.

Conclusion: Liver dysfunction inducing hepatogenous diabetes should be considered when managing patients with liver disease. Medications may be used to reduce symptoms of hypoglycemia, and in severe cases, a liver transplant may be indicated. Dietary and lifestyle changes to manage glucose and insulin levels are a cost-effective approach to increase quality of life.

Keywords: case report, cirrhosis, liver, liver transplant, hepatogenous diabetes, diabetes

undefined

Suggested Citation

Lin, Annie and Nguyen, Lillie and Avent, Michelle and Lanham, Stephanie, Management of Hepatogenous Diabetes in a Liver Transplant Patient Through Blood Sugar Regulation: A Case Report (December 6, 2020). Available at SSRN: https://ssrn.com/abstract=3744137 or http://dx.doi.org/10.2139/ssrn.3744137

Annie Lin (Contact Author)

Maryland Univ Integrative Health ( email )

7750 Montpelier Rd
Laurel, MD 20723
United States
4108889048 (Phone)
20723 (Fax)

Lillie Nguyen

Maryland Univ Integrative Health ( email )

7750 Montpelier Rd
Laurel, MD 20723
United States
4108889048 (Phone)
20723 (Fax)

Michelle Avent

Maryland Univ Integrative Health ( email )

7750 Montpelier Rd
Laurel, MD 20723
United States
4108889048 (Phone)
20723 (Fax)

Stephanie Lanham

Maryland Univ Integrative Health ( email )

7750 Montpelier Rd
Laurel, MD 20723
United States
4108889048 (Phone)
20723 (Fax)

0 References

    0 Citations

      Do you have a job opening that you would like to promote on SSRN?

      Paper statistics

      Downloads
      76
      Abstract Views
      1,670
      Rank
      647,797
      PlumX Metrics
      Plum Print visual indicator of research metrics
      • Usage
        • Abstract Views: 1659
        • Downloads: 76
      • Captures
        • Readers: 4
      • Social Media
        • Shares, Likes & Comments: 43
      see details